Mission Wealth Management, LP Moderna, Inc. Transaction History

Mission Wealth Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$101.21 - $166.61 $809 - $1,332	8 Added 0.39%	2,045 $242,000
Q1 2024 Apr 30, 2024	SELL	$85.37 - $115.44 $2,219 - $3,001	-26 Reduced 1.26%	2,037 $217,000
Q4 2023 Feb 05, 2024	BUY	$69.51 - $104.43 $143,399 - $215,439	2,063 New	2,063 $205,000
Q1 2022 Apr 25, 2022	SELL	$126.46 - $235.05 $99,524 - $184,984	-787 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $21,452 - $35,008	95 Added 13.73%	787 $200,000
Q3 2021 Nov 05, 2021	BUY	$221.9 - $484.47 $153,554 - $335,253	692 New	692 $266,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

Stay updated on Mission Wealth Management, LP with notifications on news.